1XIE K. Interleukin - 8 and human cancer biology [ J ]. Cytokine Growth Factor Rev, 2001, 12(4): 375-391.
2BRAT D J, BELLAIL A C, VAN MEIB E G. The role of Interleukin -8 and its receptors in gliomagenesis and tumoralangiogenesis [J]. Neurooncol, 2005, 7(2): 122-133.
3HOLMES W E, LEE J, KUANG W J, et al. Structure and functional expression of a human interleukin -8 receptor[ J]. Science, 1991,253(5025) : 1278 - 1280.
4THELEN M. Dancing to the tune of chemokines [ J ]. NatImmunol, 2002, 2(2): 129-134.
5MOORE B B, ARENBERG D A, STOY K, et al. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells [ J ]. Am J Pathol, 1999, 154(5) : 1503 -1512.
6INOUE K, SLATON J W, EVE B Y, et al. lnterleukin 8 expression regulates tumorigenicity and metastases in androgen - independent prostate cancer [ J ]. Clin Cancer Res, 2000, 6 (5) : 2104 -2119.
7CRONAUER M V, SCHULZ W A, BURCHARDT T, et al. The androgen receptor in hormone - refractory prostate cancer: relevance of different mechanisms of androgen receptor signalling[ J]. Int J Oncol, 2003, 23(4), 1095 -1102.
8CHEN C D, WELSBIE D S, TRAN C, et al. Molecular determinants of resistance to antiandrogen therapy [ J]. Nat Med, 2004, 10(1), 33-39.
9LEE L F, LOUIE M C, DESAI S J. et al. Interleukin-8 confers androgen - independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK [ J ]. Oncogene, 2004, 23(12) : 2197 -2205.
10ARAKI S, OMORI Y, LVN D. et al. Interleukin - 8 is a molecular determinant of androgen - independence and progression in prostate cancer[ J]. Crower Res, 2007, 67 (14) : 6854 - 6862.
4Attar RM,Takimoto CH,Gottardis MM.Castration-resistant prostate cancer:locking up the molecular escape routes.Clinical Cancer Research,2009,15 (10):3251-3255.
5Debes JD,Tindall DJ.Mechanisms of androgen-refractory prostate cancer.New England Journal of Medicine,2004,351 (15):1488-1490.
6Visakorpi T,Hyytinen E,Koivisto P,et al.In vivo amplification of the androgen receptor gene and progression of human prostate cancer.Nature genetics,1995,9(4):401-406.
8Kaushal V,Kohli M,Dennis RA,et al.Thrombin receptor expression is upregulated in prostate cancer.The Prostate,2005,66(3):273-282.
9Jiang R,Zatta A,Kin H,et al.PAR-2 activation at the time of reperfusion salvages myocardium via an ERK1/2 pathway in in vivo rat hearts.American Journal of Physiology-Heart and Circulatory Physiology,2007,293 (5):H2845-H2852.
10Borensztajn KS,Spek CA.Protease-activated receptors,apoptosis and tumor growth.Pathophysiology of Haemostasis and Thrombosis,2007,36(3-4):137-147.
